SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019926
Filing Date
2021-08-16
Accepted
2021-08-16 08:31:13
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 578014
2 ex3-1.htm EX-3.1 32494
3 ex10-1.htm EX-10.1 48317
4 ex31-1.htm EX-31.1 11392
5 ex31-2.htm EX-31.2 7990
6 ex31-3.htm EX-31.3 11294
7 ex32-1.htm EX-32.1 9916
  Complete submission text file 0001493152-21-019926.txt   3849282

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE cocp-20210630.xsd EX-101.SCH 34990
9 XBRL CALCULATION FILE cocp-20210630_cal.xml EX-101.CAL 44788
10 XBRL DEFINITION FILE cocp-20210630_def.xml EX-101.DEF 136067
11 XBRL LABEL FILE cocp-20210630_lab.xml EX-101.LAB 298749
12 XBRL PRESENTATION FILE cocp-20210630_pre.xml EX-101.PRE 225719
13 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 501852
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 211174725
SIC: 2834 Pharmaceutical Preparations